1-4 of 4
Daniel Tumas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of the BET Inhibitor GS-5829 and a BCL2 Inhibitor Resulted in Broader Activity in DLBCL and MCL Cell Lines

Jamie Bates, Saritha Kusam, Stacey Tannheimer, Astrid Clarke, Thomas Kenney, David Breckenridge, Daniel Tumas
Journal: Blood
Blood (2016) 128 (22): 5104.
https://doi.org/10.1182/blood.V128.22.5104.5104
Published: 2016
Journal Articles

The Combination of a BET Inhibitor (GS-5829) and a BTK Inhibitor (GS-4059) Potentiates DLBCL Cell Line Cell Death and Reduces Expression of MYC, IL-10, and IL-6 in Vitro

Jamie Bates, Saritha Kusam, Stacey Tannheimer, Julie Chan, Yvonne Li, David Breckenridge, Daniel Tumas
Journal: Blood
Blood (2016) 128 (22): 5116.
https://doi.org/10.1182/blood.V128.22.5116.5116
Published: 2016
Journal Articles

Combination of Idelalisib and ONO/GS-4059 in Lymphoma Cell Lines Sensitive and Resistant to BTK Inhibitors

Stacey Tannheimer, PhD, Jia Liu, PhD, Rick Sorensen, BS, Anella Yahiaoui, BS, Sarah Meadows, Li Li, PhD, Peng Yue, PhD, Kathleen S Keegan, PhD, Jamie Bates, PhD, Daniel Tumas, PhD DVM, Christophe Queva, PhD
Journal: Blood
Blood (2015) 126 (23): 3697.
https://doi.org/10.1182/blood.V126.23.3697.3697
Published: 2015
Journal Articles

Combination Effects of B Cell Receptor Pathway Inhibitors (Entospletinib, ONO/GS-4059, and Idelalisib) and a BCL-2 Inhibitor in Primary CLL Cells

Randall Jones, B.A., Mark Joseph Axelrod, PhD, Daniel Tumas, PhD DVM, Christophe Quéva, PhD, Julie Di Paolo, PhD
Journal: Blood
Blood (2015) 126 (23): 1749.
https://doi.org/10.1182/blood.V126.23.1749.1749
Published: 2015